abs374.txt	we	developed	measures	of	benefits	and	burdens	of	research	participation	in	cancerclinical	trials	using	a	sequential	mixed	methods	design	with	a	qualitative	(	n	=32)	and	quantitative	sample	(	n	=	110)	of	cancer	clinical	trial	participants	benefit-burden	items	(22	for	benefits		23	for	burdens)	were	subsequentlydeveloped	and	assessed	through	cognitive	interviewing	for	content		clarity		andmeaning		preliminary	psychometric	analyses	support	the	internal	consistencyreliability	and	construct	validity	of	benefit	(α	=		90)	and	burden	(α	=		87)research	participation	scales		item	response	theory	models	supported	thediscrimination	ability	of	the	items	on	the	scales		participants	who	had	thoughtsof	dropping	out	had	lower	benefit	scale	scores	(	p	<		001)	and	higher	burdenscores	(	p	<		001)	than	those	who	had	no	thoughts	of	dropping	out		supportingconstruct	validity		with	further	psychometric	testing		the	scale	can	be	used	todevelop	appropriate	interventions	to	address	recruitment	and	retention	of	humanparticipants	in	clinical	research	
